30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Pharmaceuticals

Arno Therapeutics Inc (ARNI)

Track

Stock chart
Ticker: ARNI Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
SUSSMAN S DONALD
See Footnote 1
1 sale — total 0 USD
Sale 30 Dec 2016
Value US$3,466,951.67 | Price 168.40 | Shares 52,535
Buy 3 Oct 2016
Value US$4,967,465.00 | Price 169.52 | Shares 81,224
Buy 15 Aug 2016
Value US$0.00 | Price 0.00 | Shares 714,285
Buy 15 Aug 2016
Value US$0.00 | Price 0.00 | Shares 102,100
Buy 15 Aug 2016
Value US$0.00 | Price 0.00 | Shares 263,017
Buy 15 Aug 2016
Value US$0.00 | Price 0.00 | Shares 349,168
Buy 15 Aug 2016
Value US$0.00 | Price 0.00 | Shares 714,285
Buy 12 Jan 2016
Value US$72,445.10 | Price 0.35 | Shares 206,986
Buy 12 Jan 2016
Value US$186,622.80 | Price 0.35 | Shares 533,208
Buy 12 Jan 2016
Value US$247,753.80 | Price 0.35 | Shares 707,868
Buy 12 Jan 2016
Value US$72,445.10 | Price 0.35 | Shares 206,986
Buy 12 Jan 2016
Value US$186,622.80 | Price 0.35 | Shares 533,208
Buy 12 Jan 2016
Value US$247,753.80 | Price 0.35 | Shares 707,868
Buy 12 Jan 2016
Value US$249,999.75 | Price 0.35 | Shares 714,285
Buy 12 Jan 2016
Value US$506,821.70 | Price 0.35 | Shares 1,448,062
Buy 12 Jan 2016
Value US$1,006,821.55 | Price 0.35 | Shares 2,876,633
Buy 12 Jan 2016
Value US$50,682.10 | Price 0.35 | Shares 144,806
Buy 12 Jan 2016
Value US$126,705.25 | Price 0.35 | Shares 362,015
Sale 4 Oct 2013
Value US$156.00 | Price 0.48 | Shares 325
Buy 22 May 2013
Value US$1,250.00 | Price 0.50 | Shares 2,500
Buy 21 May 2013
Value US$3,750.00 | Price 0.50 | Shares 7,500
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2017-01-03 2016-12-30 S Sale SUSSMAN S DONALD

See Footnote 1
52,535
168.40
US$3,466,952 		52,535 168.40 US$3,466,952
2016-10-05 2016-10-03 B Purchase TANEN DAVID M

Secretary

Executive Director
81,224
169.52
US$4,967,465 		81,224 169.52 US$4,967,465
2016-09-08 2016-08-15 B Purchase SUSSMAN S DONALD

See Footnote 1

Large shareholder
4,423
143.26
US$567,189 		4,423 143.26 US$567,189
2016-08-17 2016-08-15 B Purchase Kariv Tomer Non-Executive Director
102,100
0.00
US$0 		102,100 0.00 US$0
2016-08-17 2016-08-15 B Purchase Kariv Tomer Non-Executive Director
263,017
0.00
US$0 		263,017 0.00 US$0
2016-08-17 2016-08-15 B Purchase Kariv Tomer Non-Executive Director
349,168
0.00
US$0 		349,168 0.00 US$0
2016-08-17 2016-08-15 B Purchase Belldegrun Arie Non-Executive Director
714,285
0.00
US$0 		714,285 0.00 US$0
2016-04-11 2016-01-12 B Purchase Kariv Tomer Non-Executive Director
206,986 +110.7%
0.35
US$72,445 		206,986 +110.7% 0.35 US$72,445
2016-04-11 2016-01-12 B Purchase Kariv Tomer Non-Executive Director
533,208 +110.7%
0.35
US$186,623 		533,208 +110.7% 0.35 US$186,623
2016-04-11 2016-01-12 B Purchase Kariv Tomer Non-Executive Director
707,868 +110.7%
0.35
US$247,754 		707,868 +110.7% 0.35 US$247,754
2016-01-14 2016-01-12 B Purchase Kariv Tomer Non-Executive Director
206,986 +110.7%
0.35
US$72,445 		206,986 +110.7% 0.35 US$72,445
2016-01-14 2016-01-12 B Purchase Kariv Tomer Non-Executive Director
533,208 +110.7%
0.35
US$186,623 		533,208 +110.7% 0.35 US$186,623
2016-01-14 2016-01-12 B Purchase Belldegrun Arie Non-Executive Director
714,285 +496.7%
0.35
US$250,000 		714,285 +496.7% 0.35 US$250,000
2016-01-14 2016-01-12 B Purchase Ruchefsky Steven B Non-Executive Director
2,876,633 +180.2%
0.35
US$1,006,822 		2,876,633 +180.2% 0.35 US$1,006,822
2016-01-14 2016-01-12 B Purchase Kariv Tomer Non-Executive Director
707,868 +110.7%
0.35
US$247,754 		707,868 +110.7% 0.35 US$247,754
2016-01-14 2016-01-12 B Purchase Zukiwski Alexander A

VP & Chief Medical Officer

Executive Director
144,806 +123.7%
0.35
US$50,682 		144,806 +123.7% 0.35 US$50,682
2016-01-14 2016-01-12 B Purchase Belldegrun Arie Non-Executive Director
1,448,062 +1441.1%
0.35
US$506,822 		1,448,062 +1441.1% 0.35 US$506,822
2016-01-14 2016-01-12 B Purchase TANEN DAVID M

Secretary

Executive Director
362,015 +inf%
0.35
US$126,705 		362,015 +inf% 0.35 US$126,705
2013-10-09 2013-10-04 S Sale WEXFORD CAPITAL LP
325 -0.0%
0.48
US$156 		325 -0.0% 0.48 US$156
2013-05-23 2013-05-22 B Purchase THURMAN RANDY H Non-Executive Director
2,500 +33.3%
0.50
US$1,250 		2,500 +33.3% 0.50 US$1,250
2013-05-23 2013-05-21 B Purchase THURMAN RANDY H Non-Executive Director
7,500 +inf%
0.50
US$3,750 		7,500 +inf% 0.50 US$3,750
Explore more

More insider trading research around Arno Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America